Feasibility Study on the Medical and Economic Consequences of an Ambulatory Transient Ischemic Attack and Minor Stroke Management
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- The average cost-effectiveness ratio at 3 month
Study Overview
Brief Summary
The effectiveness of outpatient management of minor TIAs and strokes in the context of a dedicated outpatient pathway with specialized care has been demonstrated and has resulted in an 80% decrease in stroke in the year followed the AIT (EXPRESS and SOS-TIA studies) At the same time, few studies have been conducted on their economic interest and none in France.
Patient's typology (younger patient, no sequel, no disability) with Transient ischemic attack (TIA) and minor stroke (MS) makes them compatible with ambulatory management.
Detailed Description
Only two hospitals in France can take care patients with TIA or MS in an outpatient setting :Bichat hospital in Paris and Toulouse University Hospital. The effectiveness of this management has been demonstrated since recurrence stroke risk is reduced by 80% at one year. An English study (EXPRESS study) [2] showed a gain of 624 pounds with an ambulatory management compared to a conventional one. No studies are available in France on this subject.
The aim of this study is to test the feasibility of a collection of medical and economic data on a prospective way. The investigators collect medical (Cerebrovascular events, Stroke) and economic (direct and indirect costs) data concerning patients who were managed in TIA clinic in Toulouse Hospital. The medical data will be compiled with available French and International literature. The economic data will be compiled with available data in PMSI and health insurance database. This study aims to prepare a multicenter cohort to compare the cost effectiveness ratio between ambulatory and conventional management.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Hospitalization in the TIA clinic in Toulouse Hospital (a day clinic)
- •Having presented within the previous 7 days a transient ischemic attack or a minor stroke
- •Affiliated to a social protection system
- •To have given no opposition to participation in the study
Exclusion Criteria
- •Patients with a transient ischemic attack - mimic (such as migraine or seizure)
- •Patients under protection of justice
- •Pregnant and / or breastfeeding woman
Outcomes
Primary Outcomes
The average cost-effectiveness ratio at 3 month
Time Frame: 3 months
The average cost-effectiveness ratio at 3 month where the effectiveness is the 3-month cerebro vascular event rate and the costs taken into account are medical and non-medical direct costs and indirect costs limited to work stoppages.
Secondary Outcomes
- Percentage of full cost collection(1 year)
- Average cost-effectiveness ratio at one year(one year)
- Concordance between monitoring data collected in different database(1 year)
- Recurrence rate of cerebro and cardiovascular events at 7 days(7 days)
- Recurrence rate of cerebro and cardiovascular events at 3 months(3 months)
- Percentage of patients treated in TIA clinic who had first medical contact with a senior(1 day)
- Recurrence rate of cerebro and cardiovascular events at one year(one year)
- Percentage of patients with statin prescription at discharge(1 day)